Sidra Medicine to Introduce Gene-Editing Therapy for Sickle Cell Disease, Thalassemia
Sidra medicine: Sidra Medicine, a member of Qatar Foundation, announced today that it has been qualified by Vertex Pharmaceuticals as one of a limited number of hospitals in the world, to administer Casgevy, a groundbreaking, one-time CRISPR/Cas9-base…